SOX2 and in situ carcinoma: Earlier studies have suggested separated NS-CIS and a SE-CIS types [135], but the lack of methylation in CIS combined with absence of SOX2 (EC marker) expression [64,136,137] increases the likelihood of a single precursor and progression into SE or NS.